155 related articles for article (PubMed ID: 25060403)
1. Acute methoxetamine and amphetamine poisoning with fatal outcome: a case report.
Wiergowski M; Anand JS; Krzyżanowski M; Jankowski Z
Int J Occup Med Environ Health; 2014 Aug; 27(4):683-90. PubMed ID: 25060403
[TBL] [Abstract][Full Text] [Related]
2. Fatal intoxication with methoxetamine.
Adamowicz P; Zuba D
J Forensic Sci; 2015 Jan; 60 Suppl 1():S264-8. PubMed ID: 25413263
[TBL] [Abstract][Full Text] [Related]
3. Accidental intoxication with high dose of methoxetamine (MXE)--a case report.
Sein Anand J; Wiergowski M; Barwina M; Kaletha K
Przegl Lek; 2012; 69(8):609-10. PubMed ID: 23243943
[TBL] [Abstract][Full Text] [Related]
4. [Acute methoxetamine intoxication--a case report with serum and urine concentrations].
Łukasik-Głebocka M; Sommerfeld K; Tezyk A; Zielińska-Psuja B; Druzdz A
Przegl Lek; 2013; 70(8):671-3. PubMed ID: 24466717
[TBL] [Abstract][Full Text] [Related]
5. Analytical findings of an acute intoxication after inhalation of methoxetamine.
Imbert L; Boucher A; Delhome G; Cueto T; Boudinaud M; Maublanc J; Dulaurent S; Descotes J; Lachâtre G; Gaulier JM
J Anal Toxicol; 2014 Sep; 38(7):410-5. PubMed ID: 24904014
[TBL] [Abstract][Full Text] [Related]
6. An accidental fatal intoxication with methoxetamine.
Wikström M; Thelander G; Dahlgren M; Kronstrand R
J Anal Toxicol; 2013; 37(1):43-6. PubMed ID: 23111916
[TBL] [Abstract][Full Text] [Related]
7. Methoxetamine associated reversible cerebellar toxicity: three cases with analytical confirmation.
Shields JE; Dargan PI; Wood DM; Puchnarewicz M; Davies S; Waring WS
Clin Toxicol (Phila); 2012 Jun; 50(5):438-40. PubMed ID: 22578175
[TBL] [Abstract][Full Text] [Related]
8. Ketamine-like effects after recreational use of methoxetamine.
Hofer KE; Grager B; Müller DM; Rauber-Lüthy C; Kupferschmidt H; Rentsch KM; Ceschi A
Ann Emerg Med; 2012 Jul; 60(1):97-9. PubMed ID: 22237166
[TBL] [Abstract][Full Text] [Related]
9. Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: a review of case reports and preclinical findings.
Zanda MT; Fadda P; Chiamulera C; Fratta W; Fattore L
Behav Pharmacol; 2016 Sep; 27(6):489-96. PubMed ID: 27128862
[TBL] [Abstract][Full Text] [Related]
10. Methoxetamine-related deaths in the UK: an overview.
Chiappini S; Claridge H; Corkery JM; Goodair C; Loi B; Schifano F
Hum Psychopharmacol; 2015 Jul; 30(4):244-8. PubMed ID: 26216557
[TBL] [Abstract][Full Text] [Related]
11. An Impaired Driver Found to be Under the Influence of Methoxetamine.
Fassette T; Martinez A
J Anal Toxicol; 2016 Oct; 40(8):700-702. PubMed ID: 27339480
[TBL] [Abstract][Full Text] [Related]
12. Methoxetamine, a ketamine derivative, produced conditioned place preference and was self-administered by rats: Evidence of its abuse potential.
Botanas CJ; de la Peña JB; Dela Peña IJ; Tampus R; Yoon R; Kim HJ; Lee YS; Jang CG; Cheong JH
Pharmacol Biochem Behav; 2015 Jun; 133():31-6. PubMed ID: 25792291
[TBL] [Abstract][Full Text] [Related]
13. Methoxetamine: a novel ketamine analog and growing health-care concern.
Ward J; Rhyee S; Plansky J; Boyer E
Clin Toxicol (Phila); 2011 Nov; 49(9):874-5. PubMed ID: 21981756
[No Abstract] [Full Text] [Related]
14. [A patient in a methoxetamine-induced dissociative psychosis].
de Jong B; van Vuren AJ; Niesink RJ; Brunt TM
Ned Tijdschr Geneeskd; 2014; 158():A7358. PubMed ID: 24867483
[TBL] [Abstract][Full Text] [Related]
15. Detailed pharmacological evaluation of methoxetamine (MXE), a novel psychoactive ketamine analogue-Behavioural, pharmacokinetic and metabolic studies in the Wistar rat.
Horsley RR; Lhotkova E; Hajkova K; Jurasek B; Kuchar M; Palenicek T
Brain Res Bull; 2016 Sep; 126(Pt 1):102-110. PubMed ID: 27155360
[TBL] [Abstract][Full Text] [Related]
16. Out with the old, in with the new? Case reports of the clinical features and acute management of two novel designer drugs.
Misselbrook GP; Hamilton EJ
Acute Med; 2012; 11(3):157-60. PubMed ID: 22993747
[TBL] [Abstract][Full Text] [Related]
17. Neuropharmacological characterization of the new psychoactive substance methoxetamine.
Hondebrink L; Kasteel EEJ; Tukker AM; Wijnolts FMJ; Verboven AHA; Westerink RHS
Neuropharmacology; 2017 Sep; 123():1-9. PubMed ID: 28454981
[TBL] [Abstract][Full Text] [Related]
18. Methoxetamine--a novel recreational drug with potent hallucinogenic properties.
Zawilska JB
Toxicol Lett; 2014 Nov; 230(3):402-7. PubMed ID: 25128700
[TBL] [Abstract][Full Text] [Related]
19. Methoxetamine: A foe or friend?
Botanas CJ; de la Peña JB; Kim HJ; Lee YS; Cheong JH
Neurochem Int; 2019 Jan; 122():1-7. PubMed ID: 30365979
[TBL] [Abstract][Full Text] [Related]
20. Methoxetamine and its metabolites: Postmortem determination in body fluids of human cadaver.
Bursová M; Hložek T; Sokol M; Židková M; Čabala R
J Anal Toxicol; 2024 Jan; 48(1):70-74. PubMed ID: 37978578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
